WiseGuyReports.Com Publish a New Market Research Report On –“ Nanomedicine Market 2019 Global Analysis By Key Players – Merck & Co. Inc., Hoffmann-La Roche Ltd., Gilead Sciences Inc., Novartis AG, Amgen Inc., Pfizer Inc”.
Nanomedicine Industry 2019
Nanomedicine is an application of nanotechnology which refers to the medical involvement at the molecular level to treat incurable diseases. This new and highly sophisticated technology also can be used for the repairment of fully or partially damaged tissues. It operates through nano-sized tools to diagnosis and treatment of the disease. It also helps to understand the complex pathophysiology of the particular disease. This can be used for future reference and research purpose.
Today, most of the nanomedicines allow oral drug intake and the demand is becoming sky-high. Scientists are still figuring out the toxicity and the environmental impact of nanotech.
For more information or any query mail at firstname.lastname@example.org
The size of the nanomaterial is smaller or similar (1-1000mm) as compared to most of the biological molecules which further added the scope for in vitro and in vivo research. The integration of biology with nanomaterial help mankind to develop the drug-delivery vehicle, analytical tool, diagnostic tool, contrast agent, and various physical therapy applications.
According to a study, the total sale of Nanomedicine touched $XYZ billion in 2015, and it will increase significantly shortly. The study also revealed that every year a total sum of around $XYZ billion being invested in research and development purpose. The funding is increasing as well, with a rate of 45% per year.
The international nanomedicine market is expected to have a compound annual growth rate of XYZ% during the 2017-2023 period.
The way people are showing interest in Nanomedicine, the industry will grow further in the next five years.
The market can be analyzed in two aspects: Therapeutic application and locations.
Some of the applications of therapeutic areas are Cardiovascular, Anti-infectives, Oncology, Anti-inflammatory, and Neurology. Key industry players are focusing more on research and development aspect, and they are trying hard to access the permission of the clinical trial so that in future, these nano-drugs can be available in the market.
The geographical segmentation of Nanomedicine covers areas like Americas, Indo Pacific, Europe, MEA region, and rest of the world. The USA, Japan, Germany, etc. are the major country covered in the report.
Due to its advanced technology and research facility, the United States of America is leading as a country and the Americas as a region. Europe comes next to the USA in terms of market share. The Indo-Pacific and rest of the world are termed as emerging regions.
Big market players
Merck & Co. Inc., UCB SA, Sanofi, Gilead Sciences Inc., Pfizer Inc., Nanobiotix SA, Eli Lilly and Company, Novartis AG, Hoffmann-La Roche Ltd., And Amgen Inc.
Current news from the industry
Indian Institute of Technology (IIT) Delhi developed a new drug delivery platform based on nanotechnology. This drug delivery platform can improve the efficiency of human antibiotics from the cellular level. It can increase the probability of recovery from cancer-related infections.
Recently in another study, it was revealed that the use of nanodiamond supported silver nanoparticles could be used as an antibacterial agent. The process will be safer and more potent as compared to traditional methods.
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.